Literature DB >> 24740660

Variation in hospital-level risk-standardized complication rates following elective primary total hip and knee arthroplasty.

Kevin J Bozic1, Laura M Grosso2, Zhenqiu Lin2, Craig S Parzynski2, Lisa G Suter2, Harlan M Krumholz2, Jay R Lieberman3, Daniel J Berry4, Robert Bucholz5, Lein Han6, Michael T Rapp6, Susannah Bernheim2, Elizabeth E Drye2.   

Abstract

BACKGROUND: Little is known about the variation in complication rates among U.S. hospitals that perform elective total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures. The purpose of this study was to use National Quality Forum (NQF)-endorsed hospital-level risk-standardized complication rates to describe variations in, and disparities related to, hospital quality for elective primary THA and TKA procedures performed in U.S. hospitals.
METHODS: We conducted a cross-sectional analysis of national Medicare Fee-for-Service data. The study cohort included 878,098 Medicare fee-for-service beneficiaries, sixty-five years or older, who underwent elective THA or TKA from 2008 to 2010 at 3479 hospitals. Both medical and surgical complications were included in the composite measure. Hospital-specific complication rates were calculated from Medicare claims with use of hierarchical logistic regression to account for patient clustering and were risk-adjusted for age, sex, and patient comorbidities. We determined whether hospitals with higher proportions of Medicaid patients and black patients had higher risk-standardized complication rates.
RESULTS: The crude rate of measured complications was 3.6%. The most common complications were pneumonia (0.86%), pulmonary embolism (0.75%), and periprosthetic joint infection or wound infection (0.67%). The median risk-standardized complication rate was 3.6% (range, 1.8% to 9.0%). Among hospitals with at least twenty-five THA and TKA patients in the study cohort, 103 (3.6%) were better and seventy-five (2.6%) were worse than expected. Hospitals with the highest proportion of Medicaid patients had slightly higher but similar risk-standardized complication rates (median, 3.6%; range, 2.0% to 7.1%) compared with hospitals in the lowest decile (3.4%; 1.7% to 6.2%). Findings were similar for the analysis involving the proportion of black patients.
CONCLUSIONS: There was more than a fourfold difference in risk-standardized complication rates across U.S. hospitals in which elective THA and TKA are performed. Although hospitals with higher proportions of Medicaid and black patients had rates similar to those of hospitals with lower proportions, there is a continued need to monitor for disparities in outcomes. These findings suggest there are opportunities for quality improvement among hospitals in which elective THA and TKA procedures are performed.

Entities:  

Mesh:

Year:  2014        PMID: 24740660     DOI: 10.2106/JBJS.L.01639

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  43 in total

1.  Exercise, Manual Therapy, and Booster Sessions in Knee Osteoarthritis: Cost-Effectiveness Analysis From a Multicenter Randomized Controlled Trial.

Authors:  Allyn M Bove; Kenneth J Smith; Christopher G Bise; Julie M Fritz; John D Childs; Gerard P Brennan; J Haxby Abbott; G Kelley Fitzgerald
Journal:  Phys Ther       Date:  2018-01-01

2.  The Gown-glove Interface Is a Source of Contamination: A Comparative Study.

Authors:  James F Fraser; Simon W Young; Kimberly A Valentine; Nicholas E Probst; Mark J Spangehl
Journal:  Clin Orthop Relat Res       Date:  2015-07       Impact factor: 4.176

3.  Complications of Total Hip Arthroplasty: Standardized List, Definitions, and Stratification Developed by The Hip Society.

Authors:  William L Healy; Richard Iorio; Andrew J Clair; Vincent D Pellegrini; Craig J Della Valle; Keith R Berend
Journal:  Clin Orthop Relat Res       Date:  2016-02       Impact factor: 4.176

Review 4.  Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility.

Authors:  M Melanie Lyons; Nitin Y Bhatt; Elizabeth Kneeland-Szanto; Brendan T Keenan; Joanne Pechar; Branden Stearns; Nabil M Elkassabany; Stavros G Memtsoudis; Allan I Pack; Indira Gurubhagavatula
Journal:  Biomark Med       Date:  2016       Impact factor: 2.851

5.  Disparities in Knee and Hip Arthroplasty Outcomes: an Observational Analysis of the ACS-NSQIP Clinical Registry.

Authors:  Peter Cram; Gillian Hawker; John Matelski; Bheeshma Ravi; Andrew Pugely; Rajiv Gandhi; Timothy Jackson
Journal:  J Racial Ethn Health Disparities       Date:  2017-03-24

6.  The Cost of Complications Following Major Resection of Malignant Neoplasia.

Authors:  Cheryl K Zogg; Taylor D Ottesen; Kareem J Kebaish; Anoop Galivanche; Shilpa Murthy; Navin R Changoor; Donald L Zogg; Timothy M Pawlik; Adil H Haider
Journal:  J Gastrointest Surg       Date:  2018-06-26       Impact factor: 3.452

7.  Managing acute cholecystitis among Medicaid insured in New York State: opportunities to optimize care.

Authors:  Anne M Stey; Alexander J Greenstein; Arthur Aufses; Alan J Moskowitz; Natalia N Egorova
Journal:  Surg Endosc       Date:  2018-02-12       Impact factor: 4.584

8.  Consumer Choice Between Hospital-Based and Freestanding Facilities for Arthroscopy: Impact on Prices, Spending, and Surgical Complications.

Authors:  James C Robinson; Timothy T Brown; Christopher Whaley; Kevin J Bozic
Journal:  J Bone Joint Surg Am       Date:  2015-09-16       Impact factor: 5.284

9.  Outcomes Over 90-Day Episodes of Care in Medicare Fee-for-Service Beneficiaries Receiving Joint Arthroplasty.

Authors:  Addie Middleton; Yu-Li Lin; James E Graham; Kenneth J Ottenbacher
Journal:  J Arthroplasty       Date:  2017-03-30       Impact factor: 4.757

10.  Incidence and Risk Factors for Health-Care Associated Infections after Hip Operation.

Authors:  Amanda J Hessels; Mansi Agarwal; Jianfang Liu; Elaine L Larson
Journal:  Surg Infect (Larchmt)       Date:  2016-09-21       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.